Caricamento...
Current and Future Directions for PARP Inhibition
Megan Grudem, APRN, CNP, and Andrea Wahner Hendrickson, MD, reviewed the potential role of PARP inhibition in various malignancies, how to select patients who are appropriate candidates, and guidance on devising treatment plans that include PARP inhibitors for patients with ovarian or breast cancer...
Salvato in:
| Pubblicato in: | J Adv Pract Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Harborside Press LLC
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857320/ https://ncbi.nlm.nih.gov/pubmed/33598329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.3.16 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|